Urinary Incontinence
Conditions
Keywords
new type of pelvic floor rehabilitation device PHENIX U4+, Traditional pelvic floor electrical stimulation therapy instrument
Brief summary
Enrolled patients with urinary incontinence in Peking University People's Hospital, Wuhan People's Hospital, Zhongshan People's Hospital, and Jiangsu Maternity and Child Health Hospital in the Department of Gynecology, and collected baseline data. The random number table was used to divide the period into observation group and control group. The observation group was treated with a new type of pelvic floor rehabilitation therapy device PHENIX U4+, and the control group was treated with a traditional pelvic floor electrical stimulation therapy device. Follow-up observations during the treatment period and at the end of the treatment, 3 months and 6 months, the main follow-up content includes 1h pad test, 72-hour urination diary, modified Oxford muscle strength classification diagnosis, urinary incontinence-related questionnaires, new equipment inspections, etc. , Track and compare the treatment effect.
Detailed description
Use two pelvic floor treatment devices to treat urinary incontinence, collect relevant questionnaires and pelvic floor muscle strength, and compare the two treatment devices.
Interventions
DEVICEPHENIX U4+
The newly developed domestic PHENIX U4+ is relatively small in size. In addition to the smooth muscle stimulation function of the traditional therapy device, its electrical stimulation waveform setting can also stimulate the striated muscle, and adds more than 10 A3 reflex treatment options, which can inhibit Urinary reflex, resulting in symptoms related to urinary incontinence in the patient.
DEVICETraditional pelvic floor treatment instrument
Traditional pelvic floor treatment instrument commonly used in clinical practice
Sponsors
Peking University People's Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1) 18 years old and above; 2) Have a history of sexual life; 3) Plan to live locally for a long time; 4) Mild to moderate pressure, urgency or mixed urinary incontinence; 5) The patient agrees to conduct the study and signs an informed consent form.
Exclusion criteria
1. Combined pelvic organ prolapse (with extrahymen bulging); 2. Obesity (BMI\>28kg/m2, BMI=weight (kg)/height square (m2)); 3. Uncontrolled asthma and chronic obstructive pulmonary disease (COPD); 4. Combined connective tissue disease; 5. Women with unclean lochia during pregnancy, within 6 weeks of postpartum and postpartum 6. Malignant tumors; 7. Combined neurological diseases (patients with epilepsy and dementia); 8. Those with a synchronized pacemaker on their chest (biofeedback can be done).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The difference in the effective rate of urinary incontinence treatment between the two groups | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | The effective rate of urinary incontinence treatment is judged by whether it leaks urine or not |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Differences in 72-hour urination diary | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | reflect urination of 72 hours |
| Person coefficient of correlation between results of gynecological examination and new equipment examination | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | — |
| Differences in questionnaire score： PFDI-20 | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | Questionnaires reflecting pelvic floor function, lower urinary tract symptoms, and quality of life |
| Differences in questionnaire score： ICI-Q-SF | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | Questionnaires reflecting lower urinary tract symptoms |
| Differences in pelvic floor electromyography between the two groups | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | — |
| Differences in questionnaire score： UDI-6 | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | Questionnaires reflecting lower urinary tract symptoms, and quality of life |
| Differences in pelvic floor pressure test between the two groups | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | — |
| Differences in pelvic floor tension test between the two groups | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | — |
| Differences in questionnaire score： OABSS | Before treatment, immediately after treatment, three months after treatment, and six months after treatment | Questionnaires reflecting lower urinary tract symptoms |
Countries
China
Contacts
Primary Contactxiuli P Sun, professor
Outcome results
None listed